Iovance Biotherapeutics Stock Target Price and Analyst Consensus

IOVA Stock  USD 11.71  0.15  1.26%   
The current analyst and expert consensus on Iovance Biotherapeutics is Strong Buy, with 8 strong buy opinions. The current projected Iovance Biotherapeutics target price consensus is 22.36 with 14 analyst opinions. The most common way Iovance Biotherapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Iovance Biotherapeutics executives and customers to further validate their buy or sell advice. Iovance Biotherapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Iovance Biotherapeutics target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Iovance Biotherapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.
Lowest Forecast
20.35
Highest Forecast
24.82
Target Price
22.36
The current year's Gross Profit is expected to grow to about (30.3 M). In addition to that, Pretax Profit Margin is expected to decline to -355.68. At present, Iovance Biotherapeutics' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 72.9 M, whereas Net Debt is forecasted to decline to (41 M).
  
It's important to approach Iovance Biotherapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Iovance Biotherapeutics price targets

Iovance Biotherapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Iovance Biotherapeutics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Iovance Biotherapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Iovance Biotherapeutics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Iovance Biotherapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Iovance Biotherapeutics is a key component of Iovance Biotherapeutics valuation and have some predictive power on the future returns of a Iovance Biotherapeutics.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Iovance Biotherapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
5.1011.9918.88
Details
Intrinsic
Valuation
LowRealHigh
7.6114.5021.39
Details
Naive
Forecast
LowNextHigh
2.839.7216.61
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.5-0.42-0.32
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Iovance Biotherapeutics. Your research has to be compared to or analyzed against Iovance Biotherapeutics' peers to derive any actionable benefits. When done correctly, Iovance Biotherapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Iovance Biotherapeutics.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
When determining whether Iovance Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Iovance Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Iovance Biotherapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Iovance Biotherapeutics Stock:
Check out Macroaxis Advice on Iovance Biotherapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Iovance Stock analysis

When running Iovance Biotherapeutics' price analysis, check to measure Iovance Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iovance Biotherapeutics is operating at the current time. Most of Iovance Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Iovance Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iovance Biotherapeutics' price. Additionally, you may evaluate how the addition of Iovance Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Bonds Directory
Find actively traded corporate debentures issued by US companies
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
The data published in Iovance Biotherapeutics' official financial statements usually reflect Iovance Biotherapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Iovance Biotherapeutics. For example, before you start analyzing numbers published by Iovance accountants, it's critical to develop an understanding of what Iovance Biotherapeutics' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Iovance Biotherapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Iovance Biotherapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Iovance Biotherapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Iovance Biotherapeutics. Please utilize our Beneish M Score to check the likelihood of Iovance Biotherapeutics' management manipulating its earnings.